Odyssey Therapeutics earnings were N/A for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest ODTX earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$53.1M, up 0.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ODTX reported annual earnings of -$148.6M, with 14% growth.
ODTX earnings history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
ODTX Return on Equity
Insufficient data to display
ODTX Return on Assets
Insufficient data to display
Be the first to know when ODTX announces earnings.
Odyssey Therapeutics Earnings Reports & History FAQ
What were Odyssey Therapeutics's earnings last quarter?
On ODTX's earnings call on Nov 4, 2026, Odyssey Therapeutics (NASDAQ: ODTX) reported Q3 2026 earnings per share (EPS) of -$1.10, up 85.86% year over year. Total ODTX earnings for the quarter were -$53.06 million. In the same quarter last year, Odyssey Therapeutics's earnings per share (EPS) was -$7.78.
Is Odyssey Therapeutics profitable or losing money?
As of the last Odyssey Therapeutics earnings report, Odyssey Therapeutics is currently losing money. Odyssey Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2026 was N/A, a N/A decrease year over year.
What was ODTX's earnings growth in the past year?
As of Odyssey Therapeutics's earnings date in Nov 4, 2026, Odyssey Therapeutics's earnings has grown year over year. ODTX earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.